Gen9 Receives $1,655,000 New Funding

  • Feed Type
  • Date
    2/11/2011
  • Company Name
    Gen9
  • Mailing Address
    500 Technology Sq. Cambridge, MA 01239
  • Company Description
    The company is developing synthetic biology technologies.
  • Website
    Undisclosed
  • Transaction Type
    Debt
  • Transaction Amount
    $1,655,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.